Conexeu Sciences Inc.
CNXU
$10.24
-$0.72-6.57%
NASDAQ
| 04/30/2026 | 01/31/2026 | 10/31/2025 | |||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | -- | -- | -- | ||
| Cost of Revenue | -- | -- | -- | ||
| Gross Profit | -- | -- | -- | ||
| SG&A Expenses | 456.10% | 432.64% | 6,630.26% | ||
| Depreciation & Amortization | 235.29% | 966.67% | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 417.22% | 414.64% | 742.56% | ||
| Operating Income | -417.22% | -414.64% | -742.56% | ||
| Income Before Tax | -403.01% | -492.49% | -1,620.35% | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | -403.01% | -492.49% | -1,620.35% | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | -403.01% | -492.49% | -1,620.35% | ||
| EBIT | -417.22% | -414.64% | -742.56% | ||
| EBITDA | -418.59% | -413.49% | -- | ||
| EPS Basic | -132.37% | -161.77% | -645.65% | ||
| Normalized Basic EPS | -132.56% | -127.66% | -255.25% | ||
| EPS Diluted | -132.37% | -161.77% | -645.65% | ||
| Normalized Diluted EPS | -132.56% | -127.66% | -255.25% | ||
| Average Basic Shares Outstanding | 116.40% | 126.27% | 131.43% | ||
| Average Diluted Shares Outstanding | 116.40% | 126.27% | 131.43% | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||